Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hypertension

Definition of pulmonary hypertension challenged?

Nature Reviews Cardiology volume 13, pages 250–251 (2016)Cite this article

Subjects

The current definition of pulmonary hypertension (PH) is based on resting mean pulmonary arterial pressure (mPAP) ≥25 mmHg; however, analysis of long-term follow-up data now reveals increased mortality even with mPAP ≥19 mmHg. Do we need to modify the definition of PH, and what are the implications for clinical practice?

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Galie, N. et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur. Heart J. 37, 67–119 (2016).

    Article  Google Scholar 

  2. Kovacs, G., Berghold, A., Scheidl, S. & Olschewski, H. Pulmonary arterial pressure during rest and exercise in healthy subjects: a systematic review. Eur. Respir. J. 34, 888–894 (2009).

    Article  CAS  Google Scholar 

  3. Badesch, D. B. et al. Diagnosis and assessment of pulmonary arterial hypertension. J. Am. Coll. Cardiol. 54 (Suppls.), S55–S66 (2009).

    Article  Google Scholar 

  4. Maron, B. A. et al. Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the VA-CART Program. Circulation http://dx.doi.org/10.1161/CIRCULATIONAHA.115.020207 (2016).

  5. D'Alonzo, G. E. et al. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann. Intern. Med. 115, 343–349 (1991).

    CAS  PubMed  Google Scholar 

  6. Robin, E. D. The kingdom of the near-dead. The shortened unnatural life history of primary pulmonary hypertension. Chest 92, 330–334 (1987).

    Article  CAS  Google Scholar 

  7. Lewczuk, J. et al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 119, 818–823 (2001).

    Article  CAS  Google Scholar 

  8. Riedel, M., Stanek, V., Widimsky, J. & Prerovsky, I. Longterm follow-up of patients with pulmonary thromboembolism: late prognosis and evolution of hemodynamic and respiratory data. Chest 81, 151–158 (1982).

    Article  CAS  Google Scholar 

  9. Herve, P. et al. Criteria for diagnosis of exercise pulmonary hypertension. Eur. Respir. J. 46, 728–737 (2015).

    Article  Google Scholar 

  10. Naeije, R., Vonk Noordegraaf, A. & Kovacs, G. Exercise-induced pulmonary hypertension: at last! Eur. Respir. J. 46, 583–586 (2015).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Adam Torbicki is at the Department of Pulmonary Circulation and Thromboembolic Diseases, Medical Center for Postgraduate Education, ECZ-Otwock. ul. borowa 14/18, 05-400 Otwock, Poland.,

    Adam Torbicki

Authors
  1. Adam Torbicki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adam Torbicki.

Ethics declarations

Competing interests

A.T. declares that he has received honoraria for lectures and consultancy as well as investigator's honoraria from Actelion, AOP Orphan Pharmaceuticals, Bayer, MSD, and United Therapeutics.

PowerPoint slides

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Torbicki, A. Definition of pulmonary hypertension challenged?. Nat Rev Cardiol 13, 250–251 (2016). https://doi.org/10.1038/nrcardio.2016.44

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrcardio.2016.44

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing